Skip to main content

Advertisement

Log in

Development and Trends of Surgical Modalities for Breast Cancer in China: A Review of 16-Year Data

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Surgery is the most important treatment for nonmetastatic breast cancer; however, the utilization of modern surgical techniques in management of breast cancer in mainland China has not been reported.

Methods

The medical records of 5887 consecutive breast cancer patients treated surgically in the past 16 years were reviewed retrospectively; the utilization of different surgical modalities and associated clinical outcomes were analyzed.

Results

Median age of all patients was 50 (range 16–92). About 1015 patients were staged as 0–I, 3569 stage II, 517 stage III, and 786 cases could not be staged. Extensive radical mastectomy (ERM), radical mastectomy (RM), modified radical mastectomy (MRM), simple mastectomy (SM), and breast-conserving surgery (BCS) were used in 8%, 27.2%, 55.7%, 1.5%, and 6.3% of patients, respectively. In addition, 1.3% of patients received breast reconstruction. The proportion of early-stage breast cancer increased, and the surgery patterns varied. MRM gradually replaced ERM and RM. The prevalence of BCS began to increase from the mid-1990s and currently represents about 12%. The prevalence of reconstruction also increased and now accounts for 5%. Age, pathologic pattern, and TNM staging affected the choice of surgery modalities markedly. Although patients receiving RM/ERM had worse survival than those receiving BCS/MRM, the survival outcomes of these four groups were similar in the early-stage population.

Conclusions

MRM remains the most-used surgical modality in operable breast cancer, although the utilization of BCS for early-stage disease has increased rapidly in last decade. Reconstruction following mastectomy as an alternative to BCS is available. Breast-conserving therapy (BCT) and MRM provide similar local controls and long-term survival for breast cancer. Selection of appropriate candidates for a certain surgery requires an assessment of the patient’s age and clinical and pathological characteristics of the tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.
FIG. 5.
FIG. 6.

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106–130

    PubMed  Google Scholar 

  2. Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74–108

    Article  PubMed  Google Scholar 

  3. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 2005; 14:243–50

    Article  PubMed  Google Scholar 

  4. Newman LA. Locoregional control of breast cancer: surgical technique does matter. Ann Surg Oncol 2004; 11:11–3

    Article  PubMed  Google Scholar 

  5. Rohrich RJ. Minimally invasive, limited incision breast surgery: passing fad or emerging trend? Plast Reconstr Surg 2002; 110:1315–7

    Article  PubMed  Google Scholar 

  6. Singletary SE. New approaches to surgery for breast cancer. Endocr Relat Cancer 2001; 8:265–86

    Article  PubMed  CAS  Google Scholar 

  7. Cady B. Simplification of breast cancer surgery. Ann Surg Oncol 2005; 12:6–8

    Article  PubMed  Google Scholar 

  8. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333:1456–61

    Article  PubMed  CAS  Google Scholar 

  9. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347:1233–41

    Article  PubMed  Google Scholar 

  10. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347:1227–32

    Article  PubMed  Google Scholar 

  11. Martin MA, Meyricke R, O’Neill T, Roberts S. Breast-conserving surgery versus mastectomy for survival from breast cancer: the Western Australian experience. Ann Surg Oncol 2007; 14:157–64

    Article  PubMed  Google Scholar 

  12. Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol 2005; 28:289–94

    Article  PubMed  Google Scholar 

  13. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003; 98:697–702

    Article  PubMed  Google Scholar 

  14. Pomahac B, Recht A, May JW, Hergrueter CA, Slavin SA. New trends in breast cancer management: is the era of immediate breast reconstruction changing? Ann Surg 2006; 244:282–8

    Article  PubMed  Google Scholar 

  15. Fan J, Wang L, Wang XJ, et al. Breast conservative therapy in east part of China: a retrospective cohort study. J Cancer Res Clin Oncol 2006; 132:573–8

    Article  PubMed  Google Scholar 

  16. Ganz PA, Schag AC, Lee JJ, Polinsky ML, Tan SJ. Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 1992; 69:1729–38

    Article  PubMed  CAS  Google Scholar 

  17. Zhang BN, Shao ZM, Qiao XM, et al. A prospective multicenter clinical trial of breast conserving therapy for early breast cancer in China. Zhonghua Zhong Liu Za Zhi 2005; 27:680–4

    PubMed  Google Scholar 

  18. Dian D, Schwenn K, Mylonas I, et al. Quality of life among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy. J Cancer Res Clin Oncol 2007; 133:247–52

    Article  PubMed  CAS  Google Scholar 

  19. O’Brien W, Hasselgren PO, Hummel RP, et al. Comparison of postoperative wound complications and early cancer recurrence between patients undergoing mastectomy with or without immediate breast reconstruction. Am J Surg 1993; 166:1–5

    Article  PubMed  CAS  Google Scholar 

  20. Smith I, Chua S. Medical treatment of early breast cancer. IV: neoadjuvant treatment. BMJ 2006; 332:223–4

    Article  PubMed  Google Scholar 

  21. Ananian P, Houvenaeghel G, Protiere C, et al. Determinants of patients’ choice of reconstruction with mastectomy for primary breast cancer. Ann Surg Oncol 2004; 11:762–71

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This research was supported in part by the National Key Project of China (2001BA703BO5), and the Grant from Shanghai Science and Technology Committee (06dj14004, 06DZ19504).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-Min Shao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, KD., Di, GH., Wu, J. et al. Development and Trends of Surgical Modalities for Breast Cancer in China: A Review of 16-Year Data. Ann Surg Oncol 14, 2502–2509 (2007). https://doi.org/10.1245/s10434-007-9436-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9436-2

Keywords

Navigation